CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
28 hedge funds and large institutions have $56.7M invested in Cymabay Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $74.3M → $56.7M (-$17.5M)
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.45M | |
| 2 | +$2.87M | |
| 3 | +$2.6M | |
| 4 |
Morgan Stanley
New York
|
+$477K |
| 5 |
SIM
Spark Investment Management
New York
|
+$417K |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$1.61M | |
| 3 | -$1.2M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$983K |
| 5 |
Jennison Associates
New York
|
-$501K |